Credo Technology shares surge after the company beats fourth-quarter earnings and revenue estimates. Several analysts raise price targets following the company's quarterly results. Ready to turn the market's comeback into steady cash flow? Grab the top 3 stocks to buy right here.

Government and public sector agencies can now procure VIDIZMO AI readiness, development services, and AI solutions through a streamlined purchasing process.

SAN DIEGO, June 03, 2025 ( GLOBE NEWSWIRE ) -- Johnson Fistel, PLLP is investigating potential claims on behalf of Super Micro Computer, Inc. SMCI against certain of its officers and directors to hold them responsible for damages they allegedly caused the company to suffer.

CTC-501 showed significant MADRS and CGI-S score improvements in treatment-resistant depression patients. Alto paid $1.75 million upfront, with up to $71.5 million in milestones tied to treatment-resistant depression drugs. Ready to turn the market's comeback into steady cash flow?

A CURATED ART AUCTION AND CELEBRATION OF ARTISTS IN SUPPORT OF HOUSING FOR NEW YORKERS LIVING WITH HIV/AIDS

Los Angeles, CA, June 03, 2025 ( GLOBE NEWSWIRE ) -- Global entrepreneurship education nonprofit Network for Teaching Entrepreneurship ( NFTE ) has named five local student businesses as the winners of its annual West Regional Youth Entrepreneurship Challenge.

Mullen completes 800V battery testing and is moving to on-road validation for its FIVE RS vehicle. The company plans to launch the FIVE RS in Germany in December 2025, expanding to other markets in 2026. Rebound or breakdown? See how Matt Maley is trading June's market volatility, live this ...

Immix Biopharma today presented results at ASCO from its U.S. multi-center NEXICART-2 Phase 1/2 clinical trial of NXC-201, meeting its primary endpoint.

CHICAGO, June 03, 2025 ( GLOBE NEWSWIRE ) -- The American Specialty Toy Retailing Association ( Astra ) is currently hosting its flagship event, Marketplace & Academy 2025, in San Antonio, Texas, bringing together over 500 specialty toy businesses for four high-impact days of education, product ...

Shield test showed 98.6% specificity and 75% sensitivity across eight cancer types in a case-control study. NCCN now recommends the Shield blood test every three years for colorectal cancer screening. Ready to turn the market's comeback into steady cash flow? Grab the top 3 stocks to buy right ...